Philips’ new V60 Plus ventilator, designed to improve equipment efficiency and enhance clinician workflow, has received CE Mark approval.

It is designed so clinicians can adjust therapies around changing patient conditions without having to switched devices. It’s used for early intervention in respiratory failure with less invasive therapies.

Jim Alwan, business leader of Philips Hospital Respiratory Care said: “When treating respiratory patients in intensive and emergency Care settings, it’s critical for clinicians to be able to wean efficiently or to quickly escalate care depending on their patient’s condition and specific needs. This often means complex workflows and alternating devices in time-sensitive situations. We are excited to offer a comprehensive noninvasive solution that enables quick therapy and interface transitions, so clinicians can focus on providing for their patients while spending less time setting up equipment.”

While early implementation with NIV is associated with less endotracheal intubation, as well as the reduction of serious complications and adverse events in the ICU, clinicians sometimes face challenges when weaning patients off of this therapy. The V60 Plus now delivers non-invasive support for these patients, which supports clinicians to begin the weaning process sooner. By having the different, but complementary modes in one device, the V60 Plus can simplify both workflow and device availability.

Peter Lindberg, R.N., leader NIV program at St. Goran Hospital in Stockholm said: “We are delighted with the high flow function of the V60 Plus. It saves us a lot of time and space as we can use the same equipment for both NIV and high flow. When you need to wean patients from NIV to HFT, it is very simple with the one device. Additionally, the cannula is high quality, easy to adjust, soft against the patient's skin and V60 flow is much quieter than our standalone high flow system.”